BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24145241)

  • 1. Stem cells and targeted approaches to melanoma cure.
    Murphy GF; Wilson BJ; Girouard SD; Frank NY; Frank MH
    Mol Aspects Med; 2014 Oct; 39():33-49. PubMed ID: 24145241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cells initiating human melanomas.
    Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
    Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor initiation in human malignant melanoma and potential cancer therapies.
    Ma J; Frank MH
    Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of T-cell activation by malignant melanoma initiating cells.
    Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
    Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melanoma stem cells on melanoma metastasis.
    Yin Q; Shi X; Lan S; Jin H; Wu D
    Oncol Lett; 2021 Jul; 22(1):566. PubMed ID: 34113394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
    Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
    Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells and human malignant melanoma.
    Schatton T; Frank MH
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD271 is an imperfect marker for melanoma initiating cells.
    Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
    Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.
    Valyi-Nagy K; Kormos B; Ali M; Shukla D; Valyi-Nagy T
    Mol Vis; 2012; 18():588-92. PubMed ID: 22419851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning the ABCs of melanoma-initiating cells.
    Zabierowski SE; Herlyn M
    Cancer Cell; 2008 Mar; 13(3):185-7. PubMed ID: 18328422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
    Zhang S; Yang Z; Qi F
    Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor immunity and cancer stem cells.
    Schatton T; Frank MH
    Ann N Y Acad Sci; 2009 Sep; 1176():154-69. PubMed ID: 19796244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
    Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
    Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.
    Boiko AD; Razorenova OV; van de Rijn M; Swetter SM; Johnson DL; Ly DP; Butler PD; Yang GP; Joshua B; Kaplan MJ; Longaker MT; Weissman IL
    Nature; 2010 Jul; 466(7302):133-7. PubMed ID: 20596026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
    Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
    Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma stem cells: not rare, but well done.
    Girouard SD; Murphy GF
    Lab Invest; 2011 May; 91(5):647-64. PubMed ID: 21445060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.